Shares of BillionToOne, Inc. surged 8.29% in pre-market trading on Thursday, following the release of the company's first-quarter financial results that significantly exceeded analyst expectations.
The healthcare company reported Q1 earnings per share of 34 cents, dramatically surpassing the consensus estimate of 4 cents. Revenue for the quarter came in at $108.39 million, also beating the $96.89 million consensus. Furthermore, the company provided optimistic full-year 2026 revenue guidance of $450 million to $465 million, above the consensus estimate of $437.6 million.
Analyst sentiment contributed to the positive momentum, with JP Morgan raising its price target on BillionToOne to $125 from $120. The company's earnings call was described as signaling "profitable hyper-growth," highlighting continued business momentum. While BTIG reduced its price target to $130 from $140, the overall market reaction was strongly positive following the earnings and guidance announcements.
Comments